LITTLE KNOWN FACTS ABOUT HEALTHCARE NEWS.

Britain’s drug regulator authorized the Alzheimer’s drug Kisunla on Wednesday, but The federal government gained’t be paying for it following an unbiased watchdog agency reported the treatment method isn’t definitely worth the Price tag to taxpayersFifty a long time ago, Philadelphia prison officers ended a clinical testing software that ha